Phase 2 Study of Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- Acronyms MEDICARE
- 27 Jun 2016 Planned primary completion date changed from 1 May 2016 to 1 Jul 2018.
- 02 Jul 2014 New trial record